Aug-97 -
Radiation Oncology Group
EORTC 22851 – Phase III trial of open accelerated fractionation vs conventional fractionation in the radiotherapy of advanced head and neck carcinoma.
EORTC found that accelerated radiotherapy (given over a shorter period of time), improves locoregional control for patients with head and neck squamous cell carcinomas and a poor prognosis.
